, resulted in particular interest, both from the chemical and pharmacological viewpoints, as controversial results were claimed in some recent works33, according to which sulphonamides, such as SLC-149 and congeners do not show antiproliferative activity and that the CA IX in the used cell lines does not possess a catalytic role in hypoxic tumours.33 Here, CA9 is linked to neoplasm.